Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label acute bacterial skin and skin structure infections. Show all posts
Showing posts with label acute bacterial skin and skin structure infections. Show all posts
Monday, April 8, 2013

Positive results from Affinium Pharmaceuticals' Phase 2a clinical trial of AFN-1252 in ABSSSI

›
We know that,  AFN-1252, is a selective inhibitor of Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI), which is involved ...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.